Athenex, Inc. (ATNX)
|52 Week Range||0.118-1.2|
|1y Target Est||-|
|DCF Unlevered||ATNX DCF ->|
|DCF Levered||ATNX LDCF ->|
|Debt / Equity||889.97%||Strong Buy|
Upgrades & Downgrades
Latest ATNX news
Penny Stocks To Buy? 3 Stocks Under $1 To Watch Now
5 January 2023
Penny stocks under $1 to watch this month. The post Penny Stocks To Buy?
Best Penny Stocks To Buy? 10 Under $1 To Watch This Week
27 December 2022
Penny stocks to buy for under $1 but are they worth the risk? The post Best Penny Stocks To Buy?
Best Penny Stocks To Buy? 6 Under $1 To Watch Now
23 December 2022
Penny stocks under $1 to watch right now. The post Best Penny Stocks To Buy?
3 Hot Penny Stocks Under $1 To Watch This Week
21 December 2022
Penny stocks under $1 to watch this week. The post 3 Hot Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
3 Tips for Identifying Penny Stocks With High Potential
21 December 2022
Use these tips for finding penny stocks to buy in 2022 The post 3 Tips for Identifying Penny Stocks With High Potential appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks...
Why Is Athenex (ATNX) Stock Up 44% Today?
20 December 2022
Athenex (NASDAQ: ATNX ) stock is rocketing higher on Tuesday thanks to positive results from a high-risk early-stage breast cancer clinical trial. The Phase 2 study covers the use of the company's ora...
Athenex, Inc. (ATNX) CEO Johnson Lau on Q3 2022 Results - Earnings Call Transcript
6 November 2022
Athenex, Inc. (NASDAQ:ATNX ) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Tim McCarthy - MD, Investor Relations Johnson Lau - Chief Executive Officer Dan Lang - Pr...
Athenex (ATNX) Reports Q3 Loss, Tops Revenue Estimates
3 November 2022
Athenex (ATNX) delivered earnings and revenue surprises of 12.50% and 16.42%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Athenex to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
6 September 2022
BUFFALO, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the ...